Astellas’ sustained-release mirabegron formulation patent survives invalidity challenges

17th April 2025

PATENT—D. Del.: Astellas’ sustained-release mirabegron formulation patent survives invalidity challenges, (Apr 16, 2025). Law Firms Mentioned:McCarter …